Finegan B A, Lopaschuk G D, Coulson C S, Clanachan A S
Department of Anaesthesia, Faculty of Medicine, University of Alberta, Edmonton, Canada.
Circulation. 1993 Mar;87(3):900-8. doi: 10.1161/01.cir.87.3.900.
Adenosine possesses marked cardioprotective properties, but the mechanisms for this beneficial effect are unclear. The objective of this study was to determine the effect of adenosine given before ischemia or at reperfusion on mechanical function, glucose oxidation, glycolysis, and metabolite levels in isolated, paced (280 beats per minute) working rat hearts.
Hearts were perfused with Krebs-Henseleit buffer containing 11 mM glucose, 1.2 mM palmitate, and 500 microU.mL-1 insulin at an 11.5 mm Hg left atrial preload and 80 mm Hg aortic afterload. Adenosine (100 microM) pretreatment or adenosine (100 microM) at reperfusion markedly increased the recovery of mechanical function (from 44% to 81% and 96%, respectively) after 60 minutes of low-flow ischemia (coronary flow, 0.5 mL.min-1). Glucose oxidation (mumol.min-1 x g dry wt-1) was inhibited during ischemia (from 0.44 +/- 0.04 to 0.12 +/- 0.01), and this was not altered by adenosine (100 microM). During reperfusion, glucose oxidation recovered (to 0.38 +/- 0.02) and adenosine (100 microM), given at reperfusion, further increased glucose oxidation (to 0.52 +/- 0.06). The rate of glycolysis (mumol.min-1 x g dry wt-1), which was unaffected by ischemia per se, was inhibited by adenosine pretreatment (from 4.7 +/- 0.3 to 2.6 +/- 0.3). During reperfusion, glycolysis was also inhibited by adenosine relative to control (3.9 +/- 0.8) either when present during ischemia (2.6 +/- 0.6) or during reperfusion (1.4 +/- 0.4). These effects of adenosine on glucose metabolism reduced the calculated rate of H+ production attributable to glucose metabolism during the ischemic and reperfusion periods. Tissue lactate levels (mumol.g dry wt-1), which increased during ischemia (from 9.3 +/- 1.1 to 87.4 +/- 10.3) and then declined during reperfusion (to 26.2 +/- 3.7), were depressed further by adenosine pretreatment (to 19.7 +/- 4.1) and by adenosine at reperfusion (to 13.6 +/- 2.1). ATP levels (mumol.g dry wt-1), which were depressed by ischemia (from 18.1 +/- 1.1 to 10.6 +/- 1.3) and tended to be further depressed during reperfusion (to 7.1 +/- 0.7), were increased by adenosine pretreatment (to 14.1 +/- 1.2) and by adenosine at reperfusion (to 15.6 +/- 2.4).
The effects of adenosine on glucose metabolism that would tend to decrease cellular acidosis and hence, Ca2+ overload, may explain the beneficial effects of adenosine on mechanical function observed in these hearts during reperfusion after ischemia.
腺苷具有显著的心脏保护特性,但其有益作用的机制尚不清楚。本研究的目的是确定在缺血前或再灌注时给予腺苷对离体、起搏(每分钟280次)的工作大鼠心脏的机械功能、葡萄糖氧化、糖酵解及代谢物水平的影响。
心脏在11.5 mmHg的左心房预负荷和80 mmHg的主动脉后负荷下,用含有11 mM葡萄糖、1.2 mM棕榈酸酯和500 μU/mL胰岛素的Krebs-Henseleit缓冲液灌注。腺苷(100 μM)预处理或在再灌注时给予腺苷(100 μM)可显著提高低流量缺血(冠状动脉流量,0.5 mL/min)60分钟后机械功能的恢复(分别从44%提高到81%和96%)。缺血期间葡萄糖氧化(μmol/min×g干重-1)受到抑制(从0.44±0.04降至0.12±0.01),腺苷(100 μM)对此无改变。再灌注期间,葡萄糖氧化恢复(至0.38±0.02),再灌注时给予腺苷(100 μM)可进一步提高葡萄糖氧化(至0.52±0.06)。糖酵解速率(μmol/min×g干重-1)本身不受缺血影响,但腺苷预处理可抑制糖酵解(从4.7±0.3降至2.6±0.3)。再灌注期间,相对于对照组(3.9±0.8),腺苷在缺血期间(2.6±0.6)或再灌注期间(1.4±0.4)存在时均可抑制糖酵解。腺苷对葡萄糖代谢的这些作用降低了缺血和再灌注期间归因于葡萄糖代谢的H+产生计算速率。组织乳酸水平(μmol/g干重-1)在缺血期间升高(从9.3±1.1升至87.4±10.3),然后在再灌注期间下降(至26.2±3.7),腺苷预处理(至19.7±4.1)和再灌注时给予腺苷(至13.6±2.1)可使其进一步降低。ATP水平(μmol/g干重-1)因缺血而降低(从18.1±1.1降至10.6±1.3),再灌注期间往往进一步降低(至7.1±0.7),腺苷预处理(至14.1±1.2)和再灌注时给予腺苷(至15.6±2.4)可使其升高。
腺苷对葡萄糖代谢的作用倾向于减少细胞酸中毒,从而减少Ca2+超载,这可能解释了腺苷对缺血后再灌注期间这些心脏机械功能的有益作用。